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Women account for approximately one-half of all human immunodeficiency virus (HIV) infections worldwide.
Sexual transmission is the dominant mode of HIV transmission to women, and there is a concomitant associated
epidemic of transmission to infants. The majority of HIV infections in women are in sub-Saharan Africa, with
a disproportionate burden in young women !25 years of age. Acquisition and prevention of HIV infection
in women is complex and influenced by biological, behavioral, and structural factors. Efforts to reduce the
incidence of HIV infection among women in sub-Saharan African could play a substantial role in altering
global trajectories of HIV infection. Increasing access to sexual and reproductive health services, addressing
gender-based violence and social instability, reducing poverty and the need to engage in sex for survival, and
encouraging greater male responsibility are critical short-to-medium–term interventions. Efforts to find a
microbicide and HIV vaccine need to be matched with efforts to deepen understanding of acquisition of HIV
in the female genital tract to inform development of targeted molecules for prevention of HIV infection.
EPIDEMIOLOGY
In contrast to the first 2 decades of the human im-
munodeficiency virus (HIV) pandemic, currently,
women comprise approximately one-half of all adults
with HIV infection or AIDS worldwide [1]. Hetero-
sexual transmission accounts for 180% of all new HIV
infections in women. The majority of HIV-infected
women live in sub-Saharan Africa, where there is a
substantial associated concomitant epidemic of vertical
transmission of HIV. Women acquire HIV infection at
least 5–7 years earlier than do men. The prevalence of
HIV infection is 3–7-fold higher among adolescent
women than among adolescent men in sub-Saharan
Africa (Figure 1). This age and sex differential in dis-
tribution of HIV infection is considered to be a key
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driver of the generalized hyperendemic epidemics de-
scribed in this region.
Some indication of the unfolding catastrophe for
women can be gleaned from temporal trends in age-
specific prevalence of HIV infection among pregnant
women in South Africa [2]. Although peak prevalence
of HIV infection is observed among women aged 20–24
years, the magnitude of that risk has grown 8–10-fold
over 15 years. The devastation is revealed by the ex-
ponential increase over the past ∼2 decades to ap-
proximately one-third of pregnant women having HIV
infection, in comparison with the experience of birth
cohorts of 1972 women aged 20–24 years in 1992, when
HIV infection was rare in southern Africa [3].
Although the exact contribution of HIV infection
and AIDS to maternal mortality rates is unknown, there
is growing evidence that HIV infection and AIDS are
becoming the leading causes of pregnancy-related death
in some developing countries [4] and are also impor-
tant causes of death in populations with a high prev-
alence of HIV infection [5]. Notwithstanding the es-
timated 8-fold higher transmission efficiency from men
to women, compared with from women to men [6, 7],
and the magnitude of the burden of HIV infection,
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Figure 1. Age and sex distribution of HIV infection in Africa.
HIV acquisition among women is complex, multifactorial, and
not well understood. The relative contributions of age, anat-
omy, concurrent sexual relationships, condom use, sex net-
works, poverty, education, economic autonomy, power imbal-
ances between men and women, gender-based violence, access
to sexual and reproductive health services, and political and
sociocultural issues require elucidation.
BIOLOGY AND RISK OF HIV INFECTION
Age of sexual debut [8], viral load [9, 10], stage of infection
[11], route of transmission [12], anatomy, epithelial integrity,
and presence of curable sexually transmitted infections [6, 9,
11] are some biological factors associated with excess risk of
HIV infection among women. The younger age of HIV ac-
quisition in women than in men is associated with sex with
older men who are more likely to be in concurrent relationships
with multiple partners and more likely to have a higher viral
load [13].
Although there is a growing body of knowledge on HIV
acquisition through the genital tract, it is insufficient to fully
understand the biological mechanisms responsible for driving
the vulnerability in women. HIV infection occurs through cell-
associated and cell-free virus, and infection can occur through
an intact epithelium; however, the mechanism of viral entry
and passage across the mucosa remains incompletely under-
stood.
Cervical explant studies showed that thickness of the mucosal
layer could play a protective role from HIV invasion [14], and
other studies have shown that any factor that undermines the
thickness of this barrier increases the probability of HIV trans-
mission across the mucosa. Progesterone-containing contra-
ceptives have specifically been shown to lead to thinning of the
epithelium, with subsequent increased incidence of simian im-
munodeficiency virus infection in macaques [15]. Epithelial
thinning has also been demonstrated in humans [16, 17]; how-
ever, the subsequent translation into enhanced risk of HIV
infection remains to be shown [18]. Because of the widespread
use of progesterone-containing contraceptives in sub-Saharan
Africa over intrauterine devices, implants, and/or sterilization
[19], this gap in understanding requires urgent attention.
Studies investigating likely causes of breeches in the natural
defense mechanisms in the female genital tract, such as breaks
in the epithelial lining [20], douching [21], sexual intercourse
[22], cervical ectopy with combined oral contraceptive use [23],
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and cytological changes resulting from human papilloma virus
infection [6, 20], have been inadequate and equivocal in ex-
plaining the excess burden of HIV infection among women
and demand more attention. An estimated 340 million new
cases per year of curable sexually transmitted infections occur
worldwide in persons aged 15–49 years [24]; these infections
could play a contributory role in HIV acquisition [25–27].
Although there was a promising 42% reduction in incidence
rate of HIV infection in Tanzania [28] after treatment of sex-
ually transmitted infections, these results were not reproduced
in other randomized controlled trials in Uganda [29, 30] and
Zimbabwe [31]. Notwithstanding the inconsistent findings
from these randomized controlled trials, the significant sexual
and reproductive health challenge posed by the high burden
of curable sexually transmitted infections needs to be addressed
in any efforts for prevention of HIV infection.
The cervix is thought to be an efficient primary site for viral
transmission. The negative findings from the recently com-
pleted Methods for Improving Reproductive Health in Africa
(MIRA) trial, which tested the efficacy of diaphragms for pre-
vention of HIV infection, have been a setback in testing this
hypothesis [32]. More-recent studies suggest that HIV is trans-
mitted more efficiently across the uterine lining than across the
ectocervix [33, 34] and that multiple mechanisms of trans-
mission are used in the female reproductive tract [33, 34].
A deeper understanding of the female genital tract and mu-
cosal immunity is key to guiding the development of strategic
and targeted products most suitable for combating HIV infec-
tion in women. Two critical gaps in preventing HIV infection
in women relate to (1) our understanding of what underlies
transmission efficiency from men to women, compared with
from women to men, and (2) the viral-host events that occur
immediately before and after exposure to HIV. Specifically, it
is necessary to understand (1) the sequence of events required
to establish mucosal infection, (2) the role of mucosal im-
munity in preventing HIV infection, (3) characteristics of pro-
tective mucosal immune responses, (4) the role of innate im-
munity during early HIV infection, and (5) the interface
between innate and adaptive immunity to HIV infection [35].
BEHAVIOR AND RISK OF HIV INFECTION
Abstinence, monogamy, male and female condoms, voluntary
counseling and HIV testing, and medical male circumcision are
widely promulgated as the cornerstones of efforts for preven-
tion of HIV infection. However, partnership characteristics,
patterns of sexual networking, and the age differences between
partners impact on the relevance and adequacy of these factors
for HIV prevention in women.
Abstinence. Abstinence is a strategy for prevention of HIV
infection that is promoted for adolescents, especially adolescent
women. In practice, abstinence often entails either delaying
sexual initiation for a limited period or practicing secondary
abstinence (ie, a prolonged period without sexual activity for
persons who have previously been sexually active) [36, 37].
Evidence for the success of this approach remains sparse, de-
spite the widespread implementation of abstinence messages,
particularly through life-skills education in schools and faith-
based interventions aimed at reduction of risk of HIV infection.
In settings where the epidemic is generalized and the probability
of infection is high because of high disease burden, postpone-
ment of sexual initiation in women simply delays the age of
infection, but does not reduce rates of infection [38, 39]. Pro-
motion of abstinence in young women is a key intervention
(1) to enable young women to complete school and increase
their economic opportunities; (2) to enable more-informed
decision-making about when, with whom, and how to have
sex; and (3) for acquisition of the skills to communicate desires
about preventing HIV infection and unwanted pregnancies and
about other issues to protect women’s rights as autonomous
beings and to life.
Monogamy. The practice of intergenerational sexual cou-
pling between young women and older men, a common pattern
of sexual networking in sub-Saharan Africa [40, 41], has been
shown to increase the risk of HIV infection among women
almost 7-fold when the age difference is 5–7 years [13, 42].
The reason for this is that older male partners are most likely
to already be HIV infected or may engage in concurrent or
multiple partnership patterns that increase their own and their
partners’ risk of HIV infection. Such sexual partnering is an
important contributing factor to the 24.5% prevalence of HIV
infection among young adult women [39].
Young persons with multiple or concurrent sex partners also
have an increased risk of HIV infection [43], although sex and
other factors strongly influence this association [39, 44]. Con-
current relationships are more common in sub-Saharan Africa
than are 1-time casual encounters, and the average duration of
relationships is relatively long, resulting in tightly linked, over-
lapping sexual networks [45]. This link between age difference
and concurrent relationships and risk of HIV infection appears
to be restricted to younger women and older men. Young men
report concurrent relationships ∼3 times more frequently than
do young women (23% vs 8.8%); however, the prevalence of
HIV infection among young men remains lower than that
among young women [46, 47]. Interventions targeted at re-
ducing risk of HIV infection among women require more-
targeted efforts directed at boys and young men. Greater male
responsibility for actions and for risk of HIV infection is critical
for men and their sex partner(s). The risk of HIV infection
associated with concurrent partner relationships and/or sexual
relationships that involve frequent partner changes needs to be
more directly addressed.
Condoms. Numerous studies conducted over the past de-
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cade have demonstrated the steady increase in acceptability and
use of male condoms by young persons [36, 48], particularly
in settings where consistent messages are promoted and support
for continued use is provided through access to free condoms
[39, 49]. Of significance, very high levels of consistent condom
use are required to reduce incidence rates of HIV infection. A
review of studies on risk of HIV infection [50] estimated that
only ∼20% of adolescents use male condoms consistently. Al-
though 70% of young persons reported having ever used a
condom, ∼50% reported use of a condom at their last coital
encounter [39, 51–53].
Among women, partnership type strongly influences con-
dom use, with condoms generally viewed as less acceptable or
desirable in long-term partnerships based on love and trust
[54–56], but more acceptable in casual relationships. Various
obstacles to condom use include negative beliefs about and
attitudes toward condoms that are often grounded in traditional
sex constructions [46, 57]. Some studies have found that young
persons may also associate condom use with promiscuity and
sexually transmitted infections, including HIV infection and
AIDS [58–60]. Furthermore, peer pressure or stigma about
condom use inhibits actual use [61–63]. Despite comparable
efficacy rates between male and female condoms [64] and high
acceptability levels [65], limited access to female condoms and
substantially higher costs have limited uptake and use of female
condoms and, thus, an opportunity to reduce the prevalence
of HIV infection among women through a women-initiated
method.
Counseling and testing. Voluntary counseling and testing
has been shown to be efficacious in reducing risky sexual be-
havior [66] and is cost-effective as a prevention intervention
[67]. Knowledge of HIV status is an important gateway to access
of prevention or treatment services, including reducing vertical
transmission of HIV in generalized epidemic settings. However,
large numbers of individuals do not know their HIV status,
especially in sub-Saharan Africa [68]. Despite recognition of
the risk of HIV infection, fear of stigma and discrimination
and/or experience of violence remain major obstacles to HIV
testing, particularly for women, for whom there have been low
voluntary counseling and testing uptake rates in prevention of
mother-to-child transmission programs in sub-Saharan Africa
[69]. Because the primary users of antenatal services in sub-
Saharan Africa are young women aged !30 years, transfor-
mation of delivery of prevention of mother-to-child transmis-
sion programs with greater emphasis on couple counseling,
prevention of unwanted pregnancies, maintenance of HIV-un-
infected status in mothers, early initiation of antiretroviral ther-
apy for HIV-infected mothers, and assurance of safe infant
feeding practices could make a substantial difference to current
maternal and infant mortality rates and life expectancy patterns
among women in these settings.
Medical male circumcision. Three independent random-
ized controlled trials conducted in Africa have consistently
demonstrated a 50%–60% protective effect of medical male
circumcision [70–72]. Mathematical modeling has demon-
strated the substantial prevention impact of medical male cir-
cumcision in generalized HIV epidemics with low rates of male
circumcision [73]. Of significance, reducing the number of
HIV-infected male individuals is likely to reduce the risk of
HIV infection among young women in these settings, where
marriage is rare, concurrent relationships are common, con-
dom use is low, and sexual coupling with young women is the
norm. However, despite compelling scientific evidence, most
countries in sub-Saharan Africa have been slow in developing
national policies on circumcision or programmatically provid-
ing access to medical male circumcision. This provides another
missed opportunity for reducing risk of HIV infection among
young women and for implementing a highly efficacious in-
tervention for prevention of HIV infection.
Microbicides. Use of microbicides, first proposed almost 2
decades ago, represents a strategy for prevention of HIV in-
fection that women can initiate. Currently, there are 150 can-
didate microbicide products in preclinical development, and
11 products are being tested in 21 ongoing trials. An additional
16 clinical trials are planned [74]. PRO 2000 Gel (Endo Phar-
maceutical Services) and tenofovir gel are in the most advanced
stages of effectiveness testing. Thus far, only PRO 2000 Gel has
demonstrated a moderate reduction in the incidence of HIV
infection [75]. Although promising, further evidence of the
effectiveness of the PRO 2000 Gel is still required. VivaGel
(Starpharam) and dapivirine are likely to enter last-phase ef-
ficacy trials in the near future, and research has started on
combination microbicides with multiple active ingredients and/
or that target different points of viral entry. Despite numerous
scientific, ethical, and methodological challenges, microbicides
provide real potential to influence the course of the HIV ep-
idemic, are likely to be available and accessible sooner than will
HIV vaccines, and will fill an important gap for women-ini-
tiated prevention methods. Such investments and research for
an efficacious microbicide needs to continue to be a priority
in the global agenda for prevention of HIV infection.
STRUCTURAL FACTORS AND RISK OF HIV
INFECTION: SEX, POVERTY, POWER, AND
MIGRATION
There has been slow but growing recognition and appreciation
of the critical importance of how structural factors influence
risk of HIV infection, particularly the role of sex and how it
impacts HIV acquisition in women, affects access to services
and social support when persons are infected or affected by
HIV infection or AIDS, and single-handedly compounds the
effects of biological and behaviorial risk. Because of the social
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and economic constraints that limit women’s access to re-
sources in many developing countries, sex becomes a com-
modity to ensure survival. In such a context, the definition of
sex work is complex, because there are many transactions that
it can encompass, such as serial monogamous relationships;
sporadic or occasional exchange of sex for transportation,
school uniforms and fees, food, and accommodation; and the
more conventionally identified formal occupation as a sex
worker [76–78].
In settings where marriage is rare, women enter into a series
of monogamous relationships to ensure their survival and their
children’s survival [79]. Often, these women have a child to
ensure continued financial support from the father, and in the
course of a lifetime, may have several children with different
biological fathers. Because these women are preoccupied with
survival and have limited access to information and health
services, the risk of infection and options to reduce risk are
not immediate priorities for them.
Poverty and lack of economic opportunities are more pro-
nounced in rural and geographically isolated areas and influ-
ence both men and women to migrate in search of employment
and income [80]. In settings where men and women are away
from home for prolonged periods or seasonally, conjugal sta-
bility and social cohesion are disrupted; this increases the risk
of HIV and other sexually transmitted infections [81], because
the individuals are likely to establish new sexual networks that
present a greater risk of HIV acquisition. After these individuals
return home, gender role expectations and dominant ideologies
about marriage and procreation make it unlikely that they will
use methods for prevention of HIV infection, such as male
condoms [77].
The intersection of sex with age is an important determinant
in the distribution of power in any society, with younger mem-
bers of society typically having less power than older members
and younger women having less power than younger boys.
Gender-based violence is perhaps the grossest manifestation of
the power imbalance between men and women [82]. In the
context of the HIV pandemic, it renders young women even
more vulnerable to HIV infection and further limits their ability
to protect themselves. The overall power imbalances between
men and women, at both societal- and individual-relationship
levels, have their roots in adolescence [77, 83].
Notwithstanding context-specific differences, there is con-
sistency in role differences between men and women, partic-
ularly in access to resources and in decision-making authority,
that create and sustain an unequal balance of power. Typically,
men are expected to generate income through economic ac-
tivities outside the home, and women are expected to be re-
sponsible for maintaining the home through child nurturing
and rearing. Almost uniformly across the world, women have
less access to and control of productive resources outside the
home. Evidence for this imbalance in power includes the gender
gaps in literacy levels, employment patterns, access to credit,
land ownership, and school enrollment rates. This imbalance
in access to and control of productive resources translates into
an unequal balance in sexual relations in favor of men.
Although at a global level, the economic divisions between
developed countries and developing countries have increased
substantially in the past decade, the challenges in terms of
unemployment, wage gaps, literacy levels, and occupational seg-
regation are greatest for poor, indigenous women. In South
Africa, an important factor contributing to the high prevalence
of HIV infection among women is the widespread circular mi-
gration of men who work in the cities, where they have “town
wives,” while maintaining their spouses and children in rural
areas [84]. These circumstances place young women in rural
areas in a uniquely vulnerable situation for acquiring HIV. In
a rural survey, the prevalence of HIV infection among women
who saw their partners !10 days per month was 15%, compared
with 0% among women who saw their partners more fre-
quently. The prevalence of HIV infection among mobile couples
is 2–3-times higher than that among more stable couples [85].
Of significance, these structural factors render both men and
women vulnerable to HIV infection. An exclusive focus on
behaviorial and biological factors to reduce the prevalence of
HIV infection will have little impact. There is increasing evi-
dence of the positive impact of conditional cash transfers on
catalyzing adherence in substance use programs, antismoking
efforts, weight reduction, school attendance, and human de-
velopment outcomes [86–88] and of the importantly intrin-
sically sustained impact of benefits. Thus far, the impact of
providing financial incentives for reducing risk of HIV infection
remains to be established. Government efforts for prevention
of HIV infection need to be matched by the private sector, in
which the nature of occupation fosters conjugal instability, such
as mining and trucking industries, to creating conditions that
reduce the risk of HIV infection. New economic initiatives need
to be cognizant of potential sources of labor in deciding lo-
cation. Short-term gains from a more urban and central lo-
cation may be off-set by medium-to-long–term goals resulting
from premature deaths and expertise due to AIDS.
CONCLUSIONS
This article highlighted the complexity of HIV acquisition in
women, as well as the biological, behaviorial, and structural
challenges in reducing this risk. Our failure to curb the HIV
pandemic is a reflection on our failure to reduce the prevalence
of HIV infection among young women, especially in sub-Sa-
haran Africa. HIV infection and AIDS are making a substantial
impact on reducing life expectancy among women and in-
creasing maternal and infant mortality rates, especially in sub-
Saharan Africa, thus undermining the region’s efforts to meet
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the Millennium Development Goals. Despite the many chal-
lenges associated with reducing the prevalence of HIV infection
among women, there are numerous opportunities to effectively
act on now, even as efforts continue for longer-term solutions
for prevention of HIV infection.
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